Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development
GEN3G
GEN3G
Sponsor study identifier
observational
1,034
1 country
1
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This study includes 2 phases. During phase 1, pregnant women are followed over the course of pregnancy. The phase 2 is a follow-up of the mother-child dyad at 3, 5 and 10-12 year after delivery. The purpose of this phase 1 is to :
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
June 18, 2012
Actual (reported)June 20, 2012
Actual (reported)September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Diagnosis of gestational diabetes mellitus
75g oral glucose tolerance test
24-28 weeks of gestation
Phase 1: Pregnant women when they come for their first prenatal visit at the Clinique de Prélèvements et de Recherche en Grossesse. Phase 2: mothers and their child
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, J1H5N4, Canada
Guillemette L, Allard C, Lacroix M, Patenaude J, Battista MC, Doyon M, Moreau J, Menard J, Bouchard L, Ardilouze JL, Perron P, Hivert MF. Genetics of Glucose regulation in Gestation and Growth (Gen3G): a prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada. BMJ Open. 2016 Feb 3;6(2):e010031. doi: 10.1136/bmjopen-2015-010031.
maternal and child plasma, whole cord blood, serum/plasma cord blood, maternal and child white cells, placenta, maternal and child urine, child saliva, maternal and child stool, child hair
Marie-France Hivert, MD, MSc
Harvard Medical School, Harvard Prilgrim Health Care Institute
1,034 participants (actual enrollment reported by the registry).
First Submitted
June 18, 2012
First Posted
June 20, 2012
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Gestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring
Gestational Metabolic Abnormalities and Maternal and Infant Nutrition and Health
Contact the study team to confirm eligibility.
Primary Completion
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 18, 2024
Record last verified: 2024-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: